Cargando…
Reconsidering low-dose aspirin therapy for cardiovascular disease: a study protocol for physician and patient behavioral change
BACKGROUND: There are often disparities between current evidence and current practice. Decreasing the gap between desired practice outcomes and observed practice outcomes in the healthcare system is not always easy. Stopping previously recommended or variably recommended interventions may be even ha...
Autores principales: | Folks, Brittany, LeBlanc, William G, Staton, Elizabeth W, Pace, Wilson D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141566/ https://www.ncbi.nlm.nih.gov/pubmed/21703023 http://dx.doi.org/10.1186/1748-5908-6-65 |
Ejemplares similares
-
Should we reconsider the routine use of placebo controls in clinical research?
por: Avins, Andrew L, et al.
Publicado: (2012) -
Laser-induced inactivation of Plasmodium falciparum
por: LeBlanc, Danielle, et al.
Publicado: (2012) -
Reconsidering the Role of Cyclooxygenase Inhibition in the Chemotherapeutic Value of NO-Releasing Aspirins for Lung Cancer
por: Martin-Martin, Antonia, et al.
Publicado: (2019) -
Statins and aspirin in the prevention of cardiovascular disease among HIV-positive patients between controversies and unmet needs: review of the literature and suggestions for a friendly use
por: Maggi, P., et al.
Publicado: (2019) -
The cognitive cell: bacterial behavior reconsidered
por: Lyon, Pamela
Publicado: (2015)